A Sequential 2 Arm Open Label Study to Evaluate teh Effects of Encorafenib in Combination with Binimetinib In Patients with BRAF V600 Mutant Unresectable or Metastatic Melanoma or Other Advanced Solid Tumors (Array-818-103)
A Sequential 2 Arm Open Label Study to Evaluate teh Effects of Encorafenib in Combination with Binimetinib In Patients with BRAF V600 Mutant Unresectable or Metastatic Melanoma or Other Advanced Solid Tumors (Array-818-103)
Trial Category:
Melanoma
Phase
I
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
